Tension is growing over changes to the Special Access and Authorised Prescriber schemes amid concerns from cannabis firms and doctors at the potential for medicines to be swapped for alternative products by pharmacists.

Join the Cannabiz revolution

Want to stay ahead of the cannabis curve with the latest local and international news, analysis and intelligence and access to Australia's legal cannabis industry?

This article is included with our Premium subscription.

Despite an information briefing held on Monday by the Therapeutic Goods Administration (TGA) – the same day the new category-based system of approvals came into effect – critical details surrounding the reforms remain unclear.

Steve has reported for a number of consumer and B2B titles over a journalism career spanning more than three decades. He is a regulator contributor to health journal, The Medical Republic, writing on...